Nitric oxide enhancing diuretic compounds, compositions and methods of use

Details for Australian Patent Application No. 2006216665 (hide)

Owner NitroMed, Inc.

Inventors Earl, Richard A.; Gaston, Ricky D.; Fang, Xinqin; Lin, Chia-En; Garvey, David S.; Ezawa, Maiko; Letts, Gordon L.; Wey, Shiow-Jyi; Khanapure, Subhash P.; Ranatunge, Ramani R.; Stevenson, Cheri A.

Agent Peter Maxwell & Associates

Pub. Number AU-A-2006216665

PCT Pub. Number WO2006/091716

Priority 60/749,853 13.12.05 US; 60/685,027 26.05.05 US; 60/656,545 28.02.05 US; 60/692,228 21.06.05 US; 60/655,414 24.02.05 US

Filing date 24 February 2006

Wipo publication date 31 August 2006

International Classifications

A61K 31/549 (2006.01) - having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

C07D 417/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/091716 Priority application(s): WO2006/091716

10 September 2009 Assignment before Grant

  Nitromed, Inc. The application has been assigned to Nicox S.A.

22 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216669-Compositions and methods for targeted delivery of immune response modifiers

2006216656-Low distortion interlayer